Rezolute, Inc. announced that Brian Roberts, M.D., previously Senior Vice President and Head of Clinical Development, has been promoted to Chief Medical Officer. Dr. Roberts joined Rezolute in 2017 as Vice President of Clinical Development and a member of the founding management team, with responsibilities that included oversight of preclinical, regulatory, and clinical operations functions. Dr. Roberts joined Rezolute as Vice President of Clinical Development in 2017 and was promoted to Senior Vice President in 2020.

Prior to joining Rezolute, Dr. Roberts held clinical development positions of increasing responsibility at Cymabay, Inc. followed by Fibrogen, Inc, developing novel therapies for metabolic diseases and their complications, including diabetes, dyslipidemia, NASH, gout, and anemia of chronic kidney disease. He is an inventor or author on more than 25 patents and publications in the fields of Endocrinology and Metabolism. Dr. Roberts received his B.S. in biochemistry from the University of California, San Diego and his M.D. Magna Cum Laude from Georgetown University.

He completed a residency in Internal Medicine and a fellowship in Endocrinology at Stanford University, where he now also serves as an Adjunct Assistant Professor in the Division of Endocrinology.